Apical dose versus volume dose of Ruthenium-106 brachytherapy for uveal melanoma. Flanagan JPM, Fog LS, Astrahan MA, Talbot LJ, et al. Can J Ophthalmol 2024;59:e775-e783.

Read + Share

Amedeo Smart

Independent Medical Education

Flanagan JPM, Fog LS, Astrahan MA, Talbot LJ, et al. Apical dose versus volume dose of Ruthenium-106 brachytherapy for uveal melanoma. Can J Ophthalmol 2024;59:e775-e783.
PMID: 38582499